The effect of azithromycin for management of HIV-associated chronic lung disease on right heart function: Results from the BREATHE trial

The effect of azithromycin for management of HIV-associated chronic lung disease on right heart function: Results from the BREATHE trial

Background: Right heart abnormalities and pulmonary hypertension (PH) may be secondary to chronic lung disease. Chronic lung disease is common in children with HIV. In the BREATHE trial (Trial registration: NCT02426112), azithromycin (AZM) reduced the risk of acute respiratory exacerbations in child...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Edith D. Majonga, Gugulethu Newton Mapurisa, Andrea M. Rehman, Grace McHugh, Tsitsi Bandason, Hilda Mujuru, Carmen Gonzalez-Martinez, Jon O. Odland, Neil Kennedy, Rashida A. Ferrand
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Children
Adolescents
Africa
HIV
Chronic lung disease
Right heart
Diseases of the circulatory (Cardiovascular) system
RC666-701
Acceso en línea:https://doaj.org/article/b795618d2b244eca8e24f8b61cf344f4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares